Ethel S Littlefield

Title: Ethel S Littlefield: Innovator in Antiviral Compounds

Introduction

Ethel S Littlefield is a prominent inventor based in San Diego, CA (US). She has made significant contributions to the field of antiviral research, particularly in the development of compounds that target picornaviruses. With a total of 4 patents to her name, her work has the potential to impact the treatment of viral infections.

Latest Patents

One of her latest patents focuses on antipicornaviral compounds and methods for their use and preparation. These picornaviral 3C protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of picornaviral 3C proteases. The compounds, along with pharmaceutical compositions that contain them, are suitable for treating patients or hosts infected with one or more picornaviruses. Several novel methods and intermediates can be utilized to prepare these innovative inhibitors.

Career Highlights

Ethel S Littlefield is associated with Agouron Pharmaceuticals, Inc., where she has been instrumental in advancing antiviral research. Her work has garnered attention for its potential applications in treating viral infections, showcasing her expertise and dedication to the field.

Collaborations

Throughout her career, Ethel has collaborated with notable colleagues, including Stephen Evan Webber and Peter Scott Dragovich. These partnerships have contributed to her innovative research and the development of effective antiviral therapies.

Conclusion

Ethel S Littlefield's contributions to antiviral research and her innovative patents highlight her role as a leading inventor in the field. Her work continues to pave the way for advancements in the treatment of viral infections.